Doxycycline and Ursodiol for ATTR Amyloidosis: Not Ready for Prime Time

In this issue of Journal of Cardiac Failure, Karlstedt and colleagues describe a study of 53 patients with ATTR cardiac amyloidosis who were treated with a regimen of doxycycline and ursodiol.1 The authors should be congratulated on reporting a relatively large single-institution experience, and their study represents an important addition to our current knowledge.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Tags: Brief Report Source Type: research